Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 12.7M | 5.2M | 5.9M | 5.7M |
Selling general and admin | 3.4M | 2.1M | 2.8M | 7.1M |
Other operating expenses | — | — | — | — |
Operating income | -16.1M | -7.4M | -8.6M | -12.8M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 468K | -1.1M | 237K | 307K |
Pretax income | -15.7M | -7.2M | -8.4M | -12.5M |
Tax provision | — | — | — | — |
Net income | -15.7M | -7.2M | -8.4M | -12.5M |
Basic EPS | -1.4 | — | -4.5 | -6.8 |
Diluted EPS | -1.4 | — | -4.5 | -6.8 |
Basic average shares | 11.4M | — | 1.8M | 1.8M |
Diluted average shares | 11.4M | — | 1.8M | 1.8M |
EBITDA | -16.1M | -7.3M | -8.6M | -12.8M |
Net income from continuing op. | -15.7M | -7.2M | -8.4M | -12.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |